View on Pubmed.gov 8393575 | View on doi.org 10.1073/pnas.90...
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
- Howard Hughes Medical Institute, University of Chicago, IL 60637.
Abstract
While trying to identify new members of the somatostatin receptor family of G protein-coupled receptors, we isolated cDNAs from a mouse brain library encoding two related receptor-like proteins, designated msl-1 and msl-2, of 380 and 372 amino acids, respectively. There was 61% identity and 71% similarity between the sequences of msl-1 and msl-2. Among members of the G protein-coupled receptor superfamily, the sequences of both msl-1 and msl-1 were most closely related to those of the somatostatin receptors (SSTRs), having approximately 35% identity with the sequence of SSTR1. Transient expression in COS-1 cells showed that msl-1 and msl-2 did not bind somatostatin. Rather they bound opioids selectively and with high affinity and had the pharmacological properties of kappa and delta opioid receptors, respectively. Indeed, the sequence of msl-2 was identical to that of a delta opioid receptor recently cloned by other workers. Functional characterization of kappa/msl-1 and delta/msl-2 opioid receptors showed that they were coupled to G proteins and mediated opioid receptor class-specific agonist inhibition of forskolin-stimulated cAMP formation. RNA blotting studies and in situ hybridization histochemistry showed that kappa opioid receptor mRNA was expressed at high levels in brain in the neocortex, hippocampus, amygdala, medial habenula, hypothalamus (arcuate and paraventricular nuclei), locus ceruleus, and parabrachial nucleus, suggesting that this receptor may play a role in arousal and regulation of autonomic and neuroendocrine functions.
References
Med Res Rev. 1991 Jul;11(4):357-74
J Biol Chem. 1991 Aug 25;266(24):15555-8
DNA Cell Biol. 1992 Jan-Feb;11(1):1-20
Proc Natl Acad Sci U S A. 1992 May 1;89(9):4124-8
Cited by 621 citations (total)
Journal Article Research Support, U.S. Gov't, P.H.S.
Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.
Electronic publication date November 1, 1996
X H Chen [...] M W Adler et al.
We examined whether mu-antisense (AS) oligodeoxynucleotide (oligo) treatment can be used in a manner similar to the mu-selective irreversible antagonist...
Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Electronic publication date August 16, 1994
H Kong [...] T Reisine et al.
Opium and its derivatives are potent analgesics that can also induce severe side effects, including respiratory depression and addiction. Opioids...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •